ritanserin has been researched along with Kidney Diseases in 2 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Beck, W | 1 |
| Deppisch, R | 1 |
| Marshall, SM | 1 |
| Hoenich, NA | 1 |
| Thompson, MG | 1 |
| Verbeke, M | 1 |
| Van de Voorde, J | 1 |
| de Ridder, L | 1 |
| Lameire, N | 1 |
2 other studies available for ritanserin and Kidney Diseases
| Article | Year |
|---|---|
Differential effects of dialysis and ultrafiltrate from individuals with CKD, with or without diabetes, on platelet phosphatidylserine externalization.
Topics: Acetophenones; Adult; Aged; Aged, 80 and over; Benzopyrans; Blood Platelets; Case-Control Studies; C | 2008 |
Beneficial effect of serotonin 5-HT2-receptor antagonism on renal blood flow autoregulation in cyclosporin-treated rats.
Topics: Animals; Cyclosporine; Homeostasis; Kidney; Kidney Diseases; Male; Phenylephrine; Rats; Rats, Wistar | 1999 |